articles about antimicrobial in Swine news

Dashboards will help monitor trends in antimicrobial resistance patterns and detect emerging resistance profiles.

Antibiotic use in the UK pig industry has declined rapidly over the last nine years, but the latest figures from AHDB reveal there was a slight increase in 2023.

Significant decrease in cephalosporins and polypeptide antibiotics, slight increase in fluoroquinolones.

The U.S. Food and Drug Administration’s Center for Veterinary Medicine published the 2023 Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals.

At the high-level ministerial meeting, UN member countries pledged to take concrete action against antimicrobial resistance.

A new report outlines the tools and practices that can reduce the need for antimicrobials such as vaccination, biosecurity, genetics, and digital technologies.

The Netherlands proposes numerous actions with the National Action Plan for Antimicrobial Resistance 2024-2030.

New national action plan on antimicrobial resistance launched to protect people and animals from the risks of drug-resistant infections.

The initiative aims to provide countries with policy support and knowledge sharing to help reduce the need for antimicrobials in livestock production.

The VFD final rule outlines the process for authorizing the use of approved animal drugs in the feed of food-producing animals that require veterinary oversight.

World Veterinary Association and Brooke launch the world’s first Essential Veterinary Medicines List for food producing animals.

Levels of residues from veterinary drugs and other substances found in animals and animal-derived food remain low in the European Union, according to the latest report from EFSA.

Legislation being introduced will make regulations more effective and maintain the UK as an attractive place to market veterinary medicines.

Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to EFSA.

The responsible and prudent use of antimicrobials needs to be improved in all sectors - human, animal, plant/crop, and environment - to preserve their public health benefits.

The project, known as JAMRAI 2, aims at reducing the risk of exposure of citizens to antibiotic-resistant bacteria, and is supported with €50 million under the EU4Health programme, making it the largest EU-funded action on AMR to date.